🇺🇸 FDA
Patent

US 9028809

Compositions, methods and uses for expression of enterobacterium-associated peptides

granted A61KA61K2039/5256A61K2039/53

Quick answer

US patent 9028809 (Compositions, methods and uses for expression of enterobacterium-associated peptides) held by Takeda Vaccines, Inc. expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/5256, A61K2039/53, A61K39/025, A61K39/0291